BioCapital
Filter News
Found 43,533 articles
-
EpiCept Corporation Receives Initial FDA Comments on Application for Ceplene(R) Special Protocol Assessment
6/27/2011
-
NovaSom, Inc. Closes $35 Million in Equity Financing
6/27/2011
-
CEL-SCI Announces Start of Multikine Phase III Study by Teva Pharmaceutical Industries Limited in Israel
6/27/2011
-
Glycotex Inc. Releases Final Phase II Clinical Trials Results in the Clinicaltrials.gov Database and Announces the Results of the Mechanism of Action Study for its Product Candidate GLYC-101
6/27/2011
-
PharmAthene, Inc. Achieves Anthrax Vaccine Program Milestone and Successfully Completes Technology Transfer
6/27/2011
-
Intrexon Appoints Leading Life Sciences Executive to Key Leadership Position
6/27/2011
-
Sigma-Tau Pharmaceuticals Release: Financial Assistance Now Available for People with Acute Lymphoblastic Leukemia
6/27/2011
-
Focused Ultrasound Surgery Foundation Release: Video Features World's First Essential Tremor Patient Treated With Noninvasive MR-Guided Focused Ultrasound
6/27/2011
-
BIOTECanada: Canadian Biotech Industry Recognizes Its Top Performers: Gold Leaf Awards Honour Canadian Biotech Innovation
6/27/2011
-
Cook Pharmica LLC Executives to Speak at 2011 Biotechnology Industry Organization (BIO) International Convention
6/27/2011
-
Biotechnology Industry Organization (BIO): 2011 Leadership Summit: Deploying Agricultural & Industrial Biotechnologies to Meet Development Challenges
6/27/2011
-
2011 Biotechnology Industry Organization (BIO) International Convention Kicks Off Today in Washington, D.C.
6/27/2011
-
Rulings Protect Generic Drugmakers and Overturn Data-mining Ban
6/24/2011
-
Stanmore Implants Worldwide Receives US FDA Approval for its JTS Non-invasive Extendible Implant
6/24/2011
-
America's Vanishing Science Jobs
6/24/2011
-
Eli Lilly and Company CEO Blames Slower Innovation on Immigration, Tax Laws
6/24/2011
-
Singapore Health Sciences Authority Approves Emergent BioSolutions Anthrax Vaccine, BioThrax
6/24/2011
-
The Lancet Publishes Data from Protege, MacroGenics, Inc.' Phase 3 Clinical Study of Teplizumab in Type 1 Diabetes Patients
6/24/2011
-
Biotechnology Industry Organization (BIO) Praises House Passage of Patent Reform Legislation
6/24/2011
-
NovaBiotics Ltd - to Present to a World-Wide Stage at Biotechnology Industry Organization (BIO) International 2011, Washington DC, 27-30 June
6/24/2011